Bavarian Nordic

Bavarian Nordic's reported carbon emissions

Bavarian Nordic, a pharmaceutical preparation manufacturing company headquartered in Denmark, is committed to climate action with a long-term goal of achieving Net Zero by 2050, in alignment with the Paris Agreement. The company is actively working to define its carbon footprint reduction pathway, with a focus on this effort throughout 2024. In 2024, Bavarian Nordic reported total global emissions of approximately 54,365,000 kg CO2e. This figure is comprised of Scope 1 emissions totalling about 4,111,000 kg CO2e, and Scope 2 emissions (market-based) amounting to approximately 5,222,000 kg CO2e. Scope 3 emissions were the most significant contributor, reaching an estimated 45,032,000 kg CO2e. Within Scope 3, purchased goods and services represented the largest category, at about 26,111,000 kg CO2e, followed by capital goods at approximately 5,399,000 kg CO2e, and upstream transportation and distribution at roughly 4,503,000 kg CO2e. The previous year, 2023, saw total emissions of approximately 97,706,000 kg CO2e. Scope 1 emissions were around 4,364,000 kg CO2e, and Scope 2 emissions (market-based) were approximately 6,318,000 kg CO2e. Scope 3 emissions for 2023 were substantially higher, at about 87,024,000 kg CO2e, with purchased goods and services accounting for approximately 40,390,000 kg CO2e and capital goods at roughly 37,812,000 kg CO2e. Bavarian Nordic's emissions data is not cascaded from a parent organisation. The company's climate commitments include developing a clear reduction pathway and are underpinned by their dedication to minimising their environmental impact.